Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 01 2023
Historique:
received: 11 11 2021
accepted: 10 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

The processes of primitive streak formation and fate specification in the mammalian epiblast rely on complex interactions between morphogens and tissue organization. Little is known about how these instructive cues functionally interact to regulate gastrulation. We interrogated the interplay between tissue organization and morphogens by using human induced pluripotent stem cells (hiPSCs) downregulated for the morphogen regulator GLYPICAN-4, in which defects in tight junctions result in areas of disrupted epithelial integrity. Remarkably, this phenotype does not affect hiPSC stemness, but impacts on cell fate acquisition. Strikingly, cells within disrupted areas become competent to perceive the gastrulation signals BMP4 and ACTIVIN A, an in vitro surrogate for NODAL, and thus differentiate into mesendoderm. Yet, disruption of epithelial integrity sustains activation of BMP4 and ACTIVIN A downstream effectors and correlates with enhanced hiPSC endoderm/mesoderm differentiation. Altogether, our results disclose epithelial integrity as a key determinant of TGF-β activity and highlight an additional mechanism guiding morphogen sensing and spatial cell fate change within an epithelium.

Identifiants

pubmed: 36681697
doi: 10.1038/s41467-023-35965-8
pii: 10.1038/s41467-023-35965-8
pmc: PMC9867713
doi:

Substances chimiques

Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

349

Informations de copyright

© 2023. The Author(s).

Références

Hum Mol Genet. 2006 Jun 1;15(11):1894-913
pubmed: 16644866
Dev Cell. 2001 Aug;1(2):251-64
pubmed: 11702784
Dev Cell. 2020 Dec 21;55(6):679-694.e11
pubmed: 33207224
Dev Cell. 2016 Nov 7;39(3):302-315
pubmed: 27746044
Cold Spring Harb Perspect Biol. 2014 Jun 26;7(11):
pubmed: 24968703
Curr Top Dev Biol. 2018;129:1-23
pubmed: 29801527
Stem Cells. 2005 Apr;23(4):489-95
pubmed: 15790770
Stem Cell Reports. 2018 Jun 5;10(6):1751-1765
pubmed: 29779899
Methods Mol Biol. 2022;2490:251-268
pubmed: 35486251
Cell Stem Cell. 2012 Mar 2;10(3):312-26
pubmed: 22385658
Mol Cell. 2015 Jun 4;58(5):780-93
pubmed: 25936800
Dev Cell. 2006 Sep;11(3):313-23
pubmed: 16950123
Stem Cells. 2021 Sep;39(9):1137-1144
pubmed: 33932319
Mol Biol Cell. 2005 Mar;16(3):1071-81
pubmed: 15616198
Cell Stem Cell. 2010 Mar 5;6(3):215-26
pubmed: 20207225
Curr Opin Cell Biol. 2013 Apr;25(2):241-6
pubmed: 23092754
J Cell Biol. 2013 Jan 7;200(1):9-19
pubmed: 23295347
Nat Methods. 2014 Aug;11(8):847-54
pubmed: 24973948
Nat Rev Mol Cell Biol. 2009 Feb;10(2):91-103
pubmed: 19129791
EMBO J. 2007 Nov 14;26(22):4744-55
pubmed: 17948051
Stem Cell Reports. 2017 Jul 11;9(1):12-22
pubmed: 28528701
Development. 2017 Dec 1;144(23):4298-4312
pubmed: 28870989
Genes Dev. 1989 Dec;3(12A):1940-56
pubmed: 2576012
Genome Biol. 2014;15(12):550
pubmed: 25516281
Development. 2019 Mar 25;146(6):
pubmed: 30814117
Stem Cells Transl Med. 2021 May;10(5):725-742
pubmed: 33528918
Stem Cell Reports. 2021 Feb 9;16(2):354-369
pubmed: 33482102
J Membr Biol. 1980;52(2):147-59
pubmed: 6245216
Dev Biol. 2013 Nov 1;383(1):39-51
pubmed: 24021482
Biochemistry. 2004 Nov 23;43(46):14832-9
pubmed: 15544354
Development. 2018 Aug 28;145(17):
pubmed: 30082271
Cell Stem Cell. 2016 Oct 6;19(4):462-475
pubmed: 27452175
Development. 2004 Apr;131(7):1651-62
pubmed: 14998924
J Biol Chem. 2004 Aug 20;279(34):35557-63
pubmed: 15205456
Nat Commun. 2016 Mar 10;7:10834
pubmed: 26960923
Nat Biotechnol. 2005 Dec;23(12):1534-41
pubmed: 16258519
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Nat Commun. 2016 Sep 02;7:12589
pubmed: 27586544
Development. 2005 Oct;132(19):4363-74
pubmed: 16141227
Stem Cell Reports. 2022 Jul 12;17(7):1757-1771
pubmed: 35714597
Stem Cells. 2008 Sep;26(9):2300-10
pubmed: 18583540
Cell Mol Life Sci. 2011 Mar;68(6):923-9
pubmed: 18087675
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
Nat Rev Genet. 2007 May;8(5):368-81
pubmed: 17387317
Elife. 2018 Oct 09;7:
pubmed: 30298816
Annu Rev Cell Dev Biol. 2016 Oct 6;32:527-554
pubmed: 27298087
Development. 2003 May;130(10):2129-38
pubmed: 12668627
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4398-403
pubmed: 9539748
Nat Biotechnol. 2007 Sep;25(9):1015-24
pubmed: 17721512
Development. 2008 Feb;135(3):501-11
pubmed: 18171685
Stem Cells. 2012 Sep;30(9):1863-74
pubmed: 22761013
Cell. 2008 Feb 22;132(4):661-80
pubmed: 18295582
Mol Cell Biol. 2009 Apr;29(8):2092-104
pubmed: 19223464
Development. 2003 Oct;130(20):4919-29
pubmed: 12930779
Nature. 2001 Jun 21;411(6840):965-9
pubmed: 11418863
Development. 2017 Nov 1;144(21):3894-3906
pubmed: 28951435
Development. 2015 May 15;142(10):1767-76
pubmed: 25968312
Development. 2021 Jul 15;148(14):
pubmed: 34131730
Cold Spring Harb Perspect Biol. 2012 Nov 01;4(11):
pubmed: 23024173
Nat Commun. 2019 Oct 4;10(1):4516
pubmed: 31586065

Auteurs

Thomas Legier (T)

Aix Marseille Univ, CNRS, IBDM, Turing Center for Living Systems, NeuroMarseille, Marseille, France.

Diane Rattier (D)

Aix Marseille Univ, CNRS, IBDM, Turing Center for Living Systems, NeuroMarseille, Marseille, France.

Jack Llewellyn (J)

Aix Marseille Univ, CNRS, IBDM, Turing Center for Living Systems, NeuroMarseille, Marseille, France.

Thomas Vannier (T)

Aix Marseille Univ, CNRS, IBDM, Turing Center for Living Systems, NeuroMarseille, Marseille, France.

Benoit Sorre (B)

Institut Curie, Universite ́PSL, Sorbonne Universite ́, CNRS UMR168, Laboratoire Physico Chimie Curie, Paris, France.

Flavio Maina (F)

Aix Marseille Univ, CNRS, IBDM, Turing Center for Living Systems, NeuroMarseille, Marseille, France.

Rosanna Dono (R)

Aix Marseille Univ, CNRS, IBDM, Turing Center for Living Systems, NeuroMarseille, Marseille, France. rosanna.dono@univ-amu.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH